Skip to main content

GSA CAPITAL PARTNERS LLP

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1362033 LONDON, X0

Position in REGN

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$509,432
-$2,450,551 QoQ
Shares Held
817
-78.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#798
of 1,322 holders
Holding Since
Mar 2020
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GSA CAPITAL PARTNERS LLP holds $104,909,103 across 164 Biotechnology names. REGN ranks #75 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in REGN

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $509,432 817
2026-03-31 $2,959,983 3,831
2025-09-30 $1,934,208 3,440
2025-06-30 $1,093,050 2,082
2025-03-31 $1,527,225 2,408
2024-12-31 $1,407,564 1,976
2024-09-30 $665,434 633
2023-12-31 $403,135 459
2022-12-31 $259,014 359
2022-09-30 $606,205 880
2022-06-30 $313,298 530
2021-09-30 $1,348,341 2,228
2021-06-30 $211,128 378
2020-03-31 $206,058 422